Author

S. F. Gilbert

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:metabolism & bioenergetics· 1

Frequent Co-Authors

C. Annunziata· 2 shared D. Voeller· 2 shared S. Lipkowitz· 2 shared A. Catalano· 1 shared B. Tang· 1 shared C. D. House· 1 shared C. Wang· 1 shared D. J. Wisniewski· 1 shared

Activity by Year

2020-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 23 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

C. Annunziata

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Mitochondrial Matrix Protease ClpP Agonists inhibit Cancer Stem Cell Function in Breast Cancer Cells by Disrupting Mitochondrial Homeostasis

Y. E. Greer, L. Hernandez, E. M. J. Fennell, D. Voeller, R. Chari, S. F. Gilbert, B. Tang, M. Hafner, C. Annunziata, E. Iwanowicz, L. M. Graves, S. Lipkowitz

This study shows that ClpP agonists inhibit breast cancer stem cell function by disrupting mitochondrial homeostasis and multiple metabolic pathways.

bioRxiv · Mar 18, 2022Cancer Biology

Flotillin-2 regulates EGFR activation, degradation, and cancer growth

D. J. Wisniewski, M. S. Liyasova, S. Korrapati, X. Zhang, S. Ratnayake, Q. Chen, S. F. Gilbert, A. Catalano, D. Voeller, D. Meerzaman, U. J. Guha, N. Porat-Shliom, C. Annunziata, S. Lipkowitz

This study shows that Flotillin-2 negatively regulates EGFR activation, ubiquitination, trafficking, and degradation, thereby suppressing cancer growth.

bioRxiv · Mar 11, 2022 · PreprintCancer Biology

Characterization of SOX2, OCT4 and NANOG in ovarian cancer tumor-initiating cells

M. Robinson, S. F. Gilbert, J. A. Waters, O. Lujano-Olazaba, J. Lara, R. Holmberg, L. J. Alexander, S. E. Green, G. Burkeen, O. Patrus, C. Wang, C. D. House

This study evaluates SOX2, OCT4, and NANOG expression in ovarian cancer cell lines under 2-D and 3-D culture conditions, finding SOX2 is more strongly associated with tumor-initiating cells and chemotherapy resistance.

bioRxiv · Sep 8, 2020Cancer Biology